Research Article | Volume: 3, Issue: 2, February, 2013

Silibinin attenuates arsenic induced alterations in serum and hepatic lipid profiles in rats

Muthumani M and Milton Prabu S   

Open Access   

Published:  Feb 27, 2013

DOI: 10.7324/JAPS.2013.30223

To study the protective effect of silibinin against arsenic induced alterations in the serum and hepatic lipid profiles in rats. In this context, the chronic oral exposure of sodium arsenite as the source of arsenic (As) at 5mg/kg/bw with silibinin (SB) 75mg/kg/bw for 28 days. In the present experiment, the elevated levels of serum hepatic markers such as aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatise (ALP) and serum cholesterol, triglycerides, low density lipoprotein (LDL), very Low Density Lipoprotein (VLDL), tissue triglycerides and cholesterol with concomitant decrease in serum HDL and tissue phospholipids were observed in As intoxicated rats. Pre-administration of SB with As was found to protect against adverse changes in the serum and hepatic tissue lipid profile in rats. Our results suggest that SB exerts a hypolipidemic effect against arsenic induced toxicity in liver by restoring the altered levels of lipids. The protective effects of SB on serum and liver as evidenced by the clear restoration of lipid profile in rats.

Keyword:     Arsenic Silibinin Liver Lipids Rats.


Muthumani M, Milton Prabu S., Silibinin attenuates arsenic induced alterations in serum and hepatic lipid profiles in rats. J App Pharm Sci. 2013; 3 (02): 132-138.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text


Article Metrics
817 Absract views 56 Absract Downloads 873 Total
Related Search

By author names